期刊文献+

合成盐酸普拉格雷的工艺改进 被引量:6

Process Improvement on the Synthesis of Prasugrel Hydrochloride
下载PDF
导出
摘要 以邻氟溴苄为起始原料制得的格式试剂与环丙基氰反应,再经溴代、缩合、乙酰化和成盐反应制得抗血栓药物盐酸普拉格雷,总收率18.0%,其结构经1H NMR,MS和IR确证。 Prasugrel hydrochloride in overall yield of 18.0% was synthesized by the reaction of cyclopropyl cyanide with Grignard reagent of 2-fluorobenzyl bromide,then by a four-step reaction of brominetion,condensation,acetylation and salification.The structure was characterized by 1H NMR,MS and IR.
出处 《合成化学》 CAS CSCD 北大核心 2012年第1期125-127,共3页 Chinese Journal of Synthetic Chemistry
关键词 盐酸普拉格雷 抗血栓药 药物合成 工艺改进 Prasugrel hydrochloride antithrombotic drug drug synthesis process improvement
  • 相关文献

参考文献4

  • 1Jakubowski J A, WinterINTER K J, Naganuma H, et al. Prasugrel: A novel thienopyridine antiplatclet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct anfiplatelet profile [ J ]. Cardiovascular Drug Rev, 2007,25 ( 4 ) : 357 - 374. 被引量:1
  • 2AIain B, Daniel F, Jian-Pierre M, et al. Derivatives of alpha- (2-oxo-2,4,5,6,7,7a-hexahy drothleno[ 3,2- c]-5-pyridyl) phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitiors [ P ]. US 4 740 510,1988. 被引量:1
  • 3Hiroyuki K, Fumitoshi A, Atsuhiro S, et al. Tetra- hydrothienopyridine derivatives, furo and pyrrolo ana- logs thereof and their preparation and uses for inhibiting blood platelet aggregatio n[ P]. EP 0 542 411, 1993. 被引量:1
  • 4吴雪松,岑均达,郭珩.制备普拉格雷的中间体及其制备方法[P].CN101245072A,2008. 被引量:4

共引文献3

同被引文献25

  • 1Koike H,Asai F,Sùgidachi A. Tetrahydrothienopyridine derivatives,furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation[P].EP,0542411,1993. 被引量:1
  • 2Satyanarayana RM,Eswaraiah S,Venkat RG. Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts[P].WO,2009066326A2,2009. 被引量:1
  • 3Yokta NY,Miyata HY,Yamamoto YS. Production of arylcyclopropyl ketone compound[P].JP,9031010,1995. 被引量:1
  • 4小池博之,木村富美夫,浅井史敏,井上辉比古,杉立收宽,西野繁荣,津崎康则.含氢化吡啶衍生物作为其活性成分的药用组合物的制备方法[P].中国专利:CN1217186. 被引量:1
  • 5Lambropoulos J, Bergholdt AB. Method development and validation for the HPLC potency assay of prasugrel tablets [ J ]. J Pharm Bi- omed Anal,2000,24(2) :251 -258. 被引量:1
  • 6R Kishore Reddy Seerapu, Venkateswara Rao A, Lavanya P, et al. Development of Validation RP - HPLC Method For The Estimation of Prasugrel HC1 in Pure and Pharmaceutical Formulat- ions[ J]. Journal of Pharmacy Research, 2011,4 ( 9 ) : 3105 - 3107. 被引量:1
  • 7荆亚萍,申东升,熊维,邓爵安.新一代血小板抑制剂——普拉格雷[J].国际药学研究杂志,2008,35(5):373-376. 被引量:22
  • 8米亚娴,吴燕,李华龙,李立俭.反相高效液相色谱法测定巴洛沙星片的含量及有关物质[J].天津药学,2008,20(5):10-12. 被引量:4
  • 9孙志国,侯建,邹强,王国平,张越.普拉格雷的合成[J].中国医药工业杂志,2009,40(4):244-246. 被引量:16
  • 10荆亚萍,申东升,邓爵安,廖伦辉.普拉格雷中间体的合成研究[J].广东药学院学报,2009,25(3):272-274. 被引量:3

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部